Regencell Bioscience: Extended Lock-Up Creates Significant Upside Potential

Regencell Bioscience Holdings Limited has surged 23,745% in 2025, reaching a $12b market cap despite having zero revenue.

Don't Even Think About Buying Regencell Bioscience Stock Until You See This 1 Red Flag

Regencell Bioscience (RGC 4.01%) is an early-stage bioscience company. That alone should be enough to keep most investors on ...
WJFW

Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm

About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and ...

Regencell Bioscience Extends Insider Stock Lock-Up to April 2027

Detailed price information for Regencell Bioscience Holdings Ltd (RGC-Q) from The Globe and Mail including charting and trades.
Barron's

Regencell Bioscience Holdings Ltd.

About Regencell Bioscience Holdings Ltd. Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese ...
Benzinga.com

Trip.com, Regencell Bioscience, And Atlassian Are Among Top 10 Large Cap Losers Last Week (Jan. 12-Jan. 16): Are the Others in Your Portfolio?

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio? Regencell Bioscience Holdings Limited (NASDAQ: RGC) slumped 42.08% this week. Figma, Inc. (NYSE: FIG) ...
Benzinga.com

Sandisk, Bloom Energy, And Oklo Are Among the Top 10 Large-Cap Gainers Last Week (Jan. 5-Jan. 9): Are the Others in Your Portfolio?

A powerful mix of defense spending, AI infrastructure deals and takeover speculation sent several large-cap stocks sharply higher last week, reshaping the market's leaderboard. These ten large-cap ...